Cheri Ackerman

Company: Concerto Biosciences

Job title: Co-Founder & Chief Executive Officer

Seminars:

Modulating Microbial Behaviors to Treat Skin Disease: ENS-002 in Atopic Dermatitis & 33 Million Data Points for Targeted Microbial Interventions 10:45 am

Discover how Concerto’s kChip platform identified ENS‑002 by screening over 5 million microbial combinations Highlight the Phase I trial testing ENS‑002’s safety and impact on Staphylococcus aureus in AD patients Explore how microbe-based therapies like ENS‑002 can provide long-term relief without the risks of immunosuppression Preview the Skin Universe Project’s role in enabling future microbial…Read more

day: Day One AM

Roundtable Discussion: Overcoming Cell Sourcing Challenges to Advance Translational & Preclinical Dermatology Research 11:30 am

Evaluating primary human keratinocytes and fibroblasts versus immortalized or stem cell‑derived lines for disease modeling Addressing variability and reproducibility across donor-derived cells and commercial suppliers Optimizing sourcing strategies for rare or inflamed patient-derived skin samples in inflammatory and autoimmune indications Integrating 3D skin models and organoids with well-characterized cell populations to improve translational relevanceRead more

day: Day One AM